[Pharmacological effects of an alginic acid treatment in young obese subjects and its effect on changes in blood gastrin, blood glucagon, immunoreactive insulin and C-peptide].
D000293:Adolescent; D000328:Adult; D000464:Alginates / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D002648:Child; D005260:Female; D005755:Gastrins / Q000097:blood; D005934:Glucagon / Q000097:blood; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D009765:Obesity / Q000097:blood / Q000188:drug therapy*
D000464:Alginates; D001786:Blood Glucose; D002096:C-Peptide; D005755:Gastrins; D006603:Hexuronic Acids; D007328:Insulin; D020723:Glucuronic Acid; D005934:Glucagon
Effetti farmacologici di un trattamento con "acido alginico" in soggetti giovani obesi e sua azione sul movimento della gastrinemia, glucagonemia, IRI, C-peptide.